76Information to be given when supplying prescribed substance

#### 76 Information to be given when supplying prescribed substance 76 Information to be given when supplying prescribed substance > > (1) This section applies if an authorised supplier supplies a prescribed substance to a patient, a patient’s contact person or an agent of a patient (the recipient). > > > (2) The authorised supplier must, when supplying the prescribed substance, inform the recipient, in writing, of the following— > > > > > (a) that the patient is not under an obligation to self-administer the substance, > > > > > (b) that the substance must be stored— > > > > > > > (i) in a locked box that complies with the requirements stated in section 79, and > > > > > > > (ii) otherwise in accordance with other requirements provided by the authorised supplier, > > > > > (c) how to prepare and self-administer the substance, > > > > > (d) that, if the patient decides not to self-administer the substance, the patient’s contact person must give the substance to an authorised disposer for disposal, > > > > > (e) that, if the patient dies, the patient’s contact person must give any unused or remaining substance to an authorised disposer for disposal not later than 14 days after the day on which the patient dies, > > > > > (f) details of the place where any unused or remaining substance may be given to an authorised disposer for disposal. > > > (3) If the recipient is not the patient, the authorised supplier must, when supplying the prescribed substance, advise the recipient to give the information given under subsection (2) to the patient.